Gut Microbiota and Liver Dysfunction in Sepsis
Author Information
Author(s): Shahid Aqsa, Chambers Stephen, Scott-Thomas Amy, Bhatia Madhav, Fukui Hirokazu
Primary Institution: Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand
Hypothesis
The gut microbiota plays a critical role in the pathogenesis of sepsis and its associated liver dysfunction.
Conclusion
The review highlights the importance of the gut-liver axis in sepsis and suggests that microbiota-targeted therapies may improve sepsis outcomes.
Supporting Evidence
- Sepsis is associated with high mortality rates worldwide.
- The gut microbiota plays a significant role in maintaining human health and can influence sepsis outcomes.
- Disruption of the gut barrier during sepsis can exacerbate inflammation and liver injury.
- Microbiota-targeted therapies, such as probiotics and fecal microbiota transplantation, show promise in improving sepsis management.
Takeaway
This study talks about how the bacteria in our gut can affect our liver when we get very sick from infections, and it suggests new ways to help people recover.
Methodology
This is a review article summarizing recent research on the gut-liver axis in sepsis and potential therapeutic approaches.
Limitations
The review is based on existing literature and may not include all recent studies or data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website